SCHEMBL5915151

SCHEMBL5915151

c1ccc(Cc2n[nH]c(SCC3CCCCC3)n2)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.40
CTSB P07858 3/20 0.40
METAP2 P50579 5/20 0.39
HPGD P15428 2/20 0.39
RECQL P46063 1/20 0.39
BMP1 P13497 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP1A2 P05177 1/20 0.36
CYP2E1 P05181 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C8 P10632 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP2C19 P33261 1/20 0.36
KDM4E B2RXH2 1/20 0.36
KDM6B O15054 1/20 0.36
KDM4A O75164 1/20 0.36
KDM4D Q6B0I6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5915194 0.79 METAP2 (0.49) DAOCTSBMETAP2HPGDCYP1A2
SCHEMBL4197676 0.76 RAB9A (0.49) DAOMEN1KMT2ACYP1A2CYP2E1
SCHEMBL5915167 0.76 METAP2 (0.44) DAOCTSBMETAP2CYP1A2CYP2E1
SCHEMBL5915196 0.76 METAP2 (0.50) DAOCTSBMETAP2CYP1A2CYP2E1
SCHEMBL4195389 0.74 METAP2 (0.42) DAOCTSBMETAP2HPGDMEN1
SCHEMBL4344773 0.73 DAO (0.42) DAOCTSBMETAP2CYP1A2CYP2E1
SCHEMBL4201055 0.73 CYP1A2 (0.53) DAOCTSBMETAP2CYP1A2CYP2E1
SCHEMBL5915150 0.72 NPC1 (0.48) CTSBHPGDCYP1A2CYP2E1CYP2C8
SCHEMBL5915166 0.72 GPR84 (0.43) HPGDKDM4E
SCHEMBL5382382 0.72 METAP2 (0.51) DAOCTSBMETAP2KDM6BKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060247280-A1 Compounds and methods SMITHKLINE BEECHAM CORPORATION 2006-11-02 US claimed
US-20060247280-A1 Compounds and methods SMITHKLINE BEECHAM CORPORATION 2006-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247280-A1 Compounds and methods METAP2, DNPEP, METAP1 DAO 196/4885CTSB 91/4885METAP2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.